The shares of Rennova Health, Inc. have decreased by more than -79.43% this year alone. The shares recently went up by 29.80% or $0.01 and now trades at $0.01. The shares of Tyme Technologies, Inc. (NASDAQ:TYME), has slumped by -39.34% year to date as of 05/24/2018. The shares currently trade at $3.87 and have been able to report a change of 17.63% over the past one week.
The stock of Rennova Health, Inc. and Tyme Technologies, Inc. were two of the most active stocks on Thursday. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? We will analyze the growth, profitability, risk, valuation, and insider trends of both companies and see which one investors prefer.Profitability and Returns
Growth alone cannot be used to see if the company will be valuable. Shareholders will be the losers if a company invest in ventures that aren’t profitable enough to support upbeat growth. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure. These figures suggest that RNVA ventures generate a higher ROI than that of TYME.Liquidity and Financial Risk
The ability of a company to meet up with its short-term obligations and be able to clear its longer-term debts is measured using Liquidity and leverage ratios. The current ratio for RNVA is 0.30 and that of TYME is 3.40. This implies that it is easier for RNVA to cover its immediate obligations over the next 12 months than TYME.Valuation
RNVA currently trades at a P/S of 0.00 while TYME trades at a P/B of 38.70, This means that looking at the earnings, book values and sales basis, RNVA is the cheaper one. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.Analyst Price Targets and Opinions
The mistake some people make is that they think a cheap stock has more value to it. In order to know the value of a stock, there is need to compare its current price to its likely trading price in the future. The price of RNVA is currently at a -100% to its one-year price target of 555.00. Looking at its rival pricing, TYME is at a -56.17% relative to its price target of 8.83.
The stock of Tyme Technologies, Inc. defeats that of Rennova Health, Inc. when the two are compared, with TYME taking 3 out of the total factors that were been considered. TYME happens to be more profitable, generates a higher ROI, has higher cash flow per share, higher liquidity and has a lower financial risk. When looking at the stock valuation, TYME is the cheaper one on an earnings, book value and sales basis. Finally, the sentiment signal for TYME is better on when it is viewed on short interest.